INDOCONSEINDOCO REMEDIES LTD.· PharmaceuticalsHighNeutral
Announced Tue, 28 Jul · 11:54 IST

Q1 FY27: Revenue up 6%, PAT swings to profit on 97 cr one-time gain

Going ConcernEmphasis Of MatterExceptional ItemEbitda Margin ExpansionResults View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
1-day move
₹248.00
prior close
₹240.04
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+9.1+7.3+6.9+3.0
Up moveDown movePending
AI summary

Q1 FY27 revenue grew 6% YoY to about 408 crores. PAT swung to 82 crore profit from 28 crore loss, lifted by a 97 crore one-time gain from the slump sale of its Ophthalmic Business to Sunways India. Excluding this gain, pre-tax loss continued. EBITDA margin expanded to 10.3% from 3.8%. Auditors flagged a going concern uncertainty on subsidiary FPP Holding LLC, which has negative net worth of about 38 crores.

Likely market impact

One-time gain masks weak core operations. Going concern flag on subsidiary FPP Holding LLC is a key risk for investors.